Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 7/31/2014 9:04:22 PM - Followers: 444 - Board type: Free - Posts Today: 49

Cellceutix Corporation (CTIX) 
 

 

http://cellceutix.com/
 

 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
CIK:  0001355250
 
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

 

Management:   http://cellceutix.com/team/
 
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/
 

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines
 
http://cellceutix.com/category/press-release/
 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 
Investor Relations:  info@cellceutix.com
 
 


 
 


 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
Wiki
CTIX News: Cellceutix Anti-Fungal Compounds Awarded $1.5 Million SBIR Grant 06/23/2014 07:00:00 AM
CTIX News: Cellceutix Clinical Trial of Anti-Cancer Drug Kevetrin Entering Eighth Cohort 06/16/2014 07:00:00 AM
CTIX News: Cellceutix Completes Patient Enrollment in Clinical Trial of Prurisol 06/02/2014 07:00:00 AM
CTIX News: Cellceutix Signs Material Transfer Agreements for Defensin Mimetic Compounds With Leading Universities 05/27/2014 07:00:00 AM
CTIX News: Cellceutix Plans for Entry in Diabetic Foot Wound and Ulcer Market 05/19/2014 07:00:00 AM
PostSubject
#63926  Sticky Note New Blog post from Ellaruth on seeking alpha. jok 07/25/14 02:31:30 AM
#62804  Sticky Note Research and development grants for the 3 months BooDog 07/02/14 07:15:59 AM
#57289  Sticky Note Cellceutix Initiates Clinical Trial of Prurisol as New starbuxsux 03/25/14 09:02:21 AM
#51541  Sticky Note Very impressive and positive CTIX PR and presentation! TOB 01/15/14 02:41:11 PM
#39163  Sticky Note $CTIX News, SEC filings, FDA trials, misc., and chart: KarinCA 08/25/13 03:20:25 PM
#64217   CTIX is my favorite, watch out shenanigan 07/31/14 09:04:22 PM
#64216   B Phase 2 will be the first,... then cabel 07/31/14 08:48:12 PM
#64215   If we see them having a party like ETphonehome 07/31/14 08:35:26 PM
#64214   Until at least Phase 2 successful trial results frrol 07/31/14 08:30:52 PM
#64213   What we been saying about DF and BI BigKahuna 07/31/14 08:14:54 PM
#64212   Were the lights on a year ago? noretreat 07/31/14 08:08:29 PM
#64211   CallMeCrazy Thursday, 07/31/14 07:58:51 AM Apparition 07/31/14 08:07:59 PM
#64210   LOL! Yes, it's going to be a serious TheDane 07/31/14 07:53:07 PM
#64209   No news on Cohort 8 is obviously good ericseb2003 07/31/14 07:46:06 PM
#64208   Only if you can be Aspire and others BigKahuna 07/31/14 07:39:00 PM
#64207   Hooray!!! If it goes up a nickel I TheDane 07/31/14 07:11:27 PM
#64206   You're safe- my 1.64 didn't fill. It'll only warrenthomas4001 07/31/14 06:28:42 PM
#64205   Why won't this explode? why? Why? Why? Is BigKahuna 07/31/14 06:28:32 PM
#64204   Lol yes just making sure they're not a tombrady12nh 07/31/14 06:24:03 PM
#64203   I did too tombrady a year ago youssef 07/31/14 06:07:25 PM
#64202   So you are a peeping Tom... iamactixaddict 07/31/14 06:01:10 PM
#64201   I looked thru the office windows In Beverly today-lights tombrady12nh 07/31/14 05:49:57 PM
#64200   Technicals are sound. 20 dollars a share soon shenanigan 07/31/14 05:24:14 PM
#64198   Wow, no booster here today to tell us maz100577 07/31/14 04:15:50 PM
#64197   July in the books... GregChase 07/31/14 04:03:49 PM
#64196   lmao TD, good luck! BooDog 07/31/14 04:03:48 PM
#64194   Brilacidin may not be the answer, but the CallMeCrazy 07/31/14 01:12:29 PM
#64193   I keep reading about various hard to treat thefamilyman 07/31/14 12:21:25 PM
#64192   I just bought 1000 at $1.64??? How? Usually TheDane 07/31/14 10:42:15 AM
#64191   I believe that's correct. Continuing the aquarium CallMeCrazy 07/31/14 10:31:46 AM
#64190   I believe the P2B data will be unblinded CallMeCrazy 07/31/14 10:17:55 AM
#64189   And the aquarium (membrane) won't hold water again... GregChase 07/31/14 10:16:51 AM
#64188   Is this the timeline for "B"? GregChase 07/31/14 10:14:59 AM
#64187   THANKS FOR POSTING THAT!! cabel 07/31/14 10:13:48 AM
#64186   Once a hole is blown (or cut) into CallMeCrazy 07/31/14 10:13:42 AM
#64185   Existing antibacterials do two things to fight bacterial DaubersUP 07/31/14 10:07:29 AM
#64184   And we will find that out probably in DaubersUP 07/31/14 09:46:01 AM
#64183   So in other words,... once a big hole cabel 07/31/14 09:45:59 AM
#64182   I think another good analogy regarding how B CallMeCrazy 07/31/14 09:42:02 AM
#64181   I was thinking of an analogy to describe cabel 07/31/14 08:45:52 AM
#64180   Excellent... I suppose it won't slow the relentless macnqueso 07/31/14 08:41:21 AM
#64179   remember the timeless saying.... "Doctor's orders" Matagordaville 07/31/14 08:36:14 AM
#64178   Standard practice for Data Release In Clinical Trials: CallMeCrazy 07/31/14 07:58:51 AM
#64177   We'll see which of us is right when georgejjl 07/31/14 07:30:55 AM
#64176   We're on such a roll here BigK. May BooDog 07/31/14 04:26:27 AM
#64175   That conversion in the link is used primarily BigKahuna 07/31/14 02:11:15 AM
#64174   Apparition - We understand your views on who RJFL 07/31/14 01:47:17 AM
#64173   DF isn't running squat. Company sponsored trial. Apparition 07/31/14 01:12:53 AM
#64172   The latest cohort is being treated with a georgejjl 07/31/14 01:03:00 AM
#64171   Make no mistake, I believe there's good things Apparition 07/31/14 01:00:52 AM
#64170   The dosage in humans is currently 215 mg/m2, BigKahuna 07/31/14 12:50:33 AM
#64169   Quality never goes out of style, and the etradeedge 07/31/14 12:00:40 AM
#64168   Do not expect miracles from Kevetrin georgejjl 07/30/14 11:38:05 PM
#64167   Autism http://cellceutix.com/autism/#sthash.SLjRKqIR.dpbs Good luck and [b georgejjl 07/30/14 11:33:16 PM
#64166   nice :-) grizzlyman 07/30/14 11:15:17 PM
PostSubject